Pharma Pulse 8/12/24: Balancing Profitability and Mission, Minority Groups Remain Underrepresented in Vitiligo Trials & more

Balancing Profitability and Mission

In this part of his Pharmaceutical Executive video interview, Brian Hillberdink, EVP, LEO Pharma and President of LEO Pharma's US affiliate, talks about how they balance the need for profitability with the mission of providing treatments for rare diseases.

Minority Groups Remain Underrepresented in Vitiligo Trials, Study Finds

Many vitiligo studies don't include enough people with darker skin types, which often leads to missing key demographic details.

Merck Buying Drug Targeting B-Cell Diseases for Up to $1.3 Billion

Merck will acquire full global rights to clinical-stage bispecific antibody CN201 from Curon Biopharmaceutical.

ePharmacies Strategic Business Report 2024: Market to Reach $323.8 Billion by 2030 - Expansion into Rural and Remote Areas Expands Opportunities

The "ePharmacies - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The global market for ePharmacies is estimated at US$97.9 Billion in 2023 and is projected to reach US$323.8 Billion by 2030, growing at a CAGR of 18.6% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

HDA - Healthcare Distribution Alliance on LinkedIn

In a recent interview with Pharmaceutical Commerce Magazine, Michael Rowe of Two Labs provided an overview of how #DSCSA legislation will ensure pharmaceutical traceability and what this means for the future of the healthcare supply chain. Learn more: https://bit.ly/3LZmlve

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs